BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7599460)

  • 21. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter.
    Tam MR; Emmons SL; Pollack SB
    J Immunol; 1980 Feb; 124(2):650-5. PubMed ID: 6985934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of decline of natural killer cell activity in Corynebacterium parvum-treated mice: inhibition by erythroblasts and Thy 1.2+ lymphocytes.
    Savary CA; Lotzová E
    J Natl Cancer Inst; 1987 Sep; 79(3):533-41. PubMed ID: 2887687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-2-induced activation of natural killer activity in spleen cells from old and young mice.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1984 Apr; 51(4):719-26. PubMed ID: 6608487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of glucocorticoid action on murine natural killer cell activity.
    Cox WI; Holbrook NJ; Friedman H
    J Natl Cancer Inst; 1983 Nov; 71(5):973-81. PubMed ID: 6580499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lack of suppressor cell activity for natural killer cells in infant, aged and a low responder strain of mice.
    Nasrallah AG; Gallagher MT; Datta SK; Priest EL; Trentin JJ
    Biomedicine; 1981 Dec; 34(4):180-3. PubMed ID: 6211200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in NK cell number and turnover rate during acute viral infection.
    Biron CA; Turgiss LR; Welsh RM
    J Immunol; 1983 Sep; 131(3):1539-45. PubMed ID: 6886424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo.
    Kung SK; Miller RG
    J Immunol; 1997 Mar; 158(6):2616-26. PubMed ID: 9058794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.
    Savary CA; Lotzová E
    J Immunol; 1978 Jan; 120(1):239-43. PubMed ID: 342602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.
    Nilsson N; Carlsten H
    Cell Immunol; 1994 Oct; 158(1):131-9. PubMed ID: 8087860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
    Ofir R; Weinstein Y; Rager-Zisman B
    Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
    Farram E; Targan SR
    J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer-type lysis of thymocytes from young mice by normal spleen cells in vitro.
    Granberg SC; Patel MR; Linna TJ
    Nat Immun Cell Growth Regul; 1985; 4(4):184-92. PubMed ID: 3877866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of natural killer cell activity by Friend murine leukemia virus.
    Moody DJ; Specter S; Bendinelli M; Friedman H
    J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of natural killer cell activity in spleens of infant, aged, and low responder strain mice by Corynebacterium parvum.
    Gallagher MT; Nasrallah AG; Datta SK; Priest EL; Trentin JJ
    Exp Hematol; 1981 Feb; 9(2):149-55. PubMed ID: 7238649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of low natural killer cell activity in 89Sr-treated mice.
    Mellen PF; Lust JA; Bennett M; Kumar V
    Eur J Immunol; 1982 May; 12(5):442-5. PubMed ID: 6212259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defects of immune cells in the senescence-accelerated mouse: a model for learning and memory deficits in the aged.
    Abe Y; Yuasa M; Kajiwara Y; Hosono M
    Cell Immunol; 1994 Aug; 157(1):59-69. PubMed ID: 8039253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the secondary in vitro antibody response by endogenous natural killer cells: kinetics, isotype preference, and non-identity with T suppressor cells.
    Robles CP; Pollack SB
    J Immunol; 1986 Oct; 137(8):2418-24. PubMed ID: 2944955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.